NALT1: A Potential Drug Target and Biomarker for Various Diseases

Target Name: NALT1

NCBI ID: G101928483

NALT1

Other Name(s): LINC01573 | MIR4674HG | NALT | TCONS_l2_00029132 | NOTCH1 associated lncRNA in T cell acute lymphoblastic leukemia 1

NALT1: A Potential Drug Target and Biomarker for Various Diseases

NALT1 (LINC01573) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. NALT1 is a non-coding RNA molecule that has been shown to play a role in regulating gene expression and has been linked to the development and progression of various diseases.

One of the key features of NALT1 is its ability to interact with other proteins, including known drug targets. For example, studies have shown that NALT1 can interact with the protein known as SMAP, which is a transcription factor that is involved in the regulation of gene expression. This interaction suggests that NALT1 may be a drug target for diseases that are characterized by the over-expression or dysfunction of SMAP.

Another potential mechanism by which NALT1 may be involved in the development of disease is its role in the regulation of cellular processes that are critical for maintaining tissue homeostasis. Studies have shown that NALT1 is involved in the regulation of cell adhesion, which is critical for the maintenance of tissues and organs and is often disrupted in diseases such as cancer. Additionally, NALT1 has been shown to play a role in the regulation of cell proliferation, which is a critical process for the development and maintenance of tissues and organs.

In addition to its potential role in drug targeting and cellular processes, NALT1 has also been shown to be involved in the regulation of gene expression in cancer. Studies have shown that NALT1 can be overexpressed in cancer cells and that this overexpression is associated with the development and progression of cancer. Additionally, NALT1 has been shown to play a role in the regulation of the expression of genes involved in cell adhesion and migration, which are critical processes for the development and progression of cancer.

Overall, the study of NALT1 is significant because it suggests that this gene may be a potential drug target and biomarker for a wide range of diseases. Further research is needed to fully understand the role of NALT1 in disease and to develop effective treatments.

Protein Name: NOTCH1 Associated LncRNA In T Cell Acute Lymphoblastic Leukemia 1

The "NALT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NALT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets